Isonicotinic Acid

Isonicotinic Acid

SCHEMBL25219686

O=C(O)c1ccncc1.[CaH2]

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAPRT Q6XQN6 2/20 0.94
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
TSHR P16473 2/20 0.58
TP53 P04637 1/20 0.58
ALDH1A1 P00352 4/20 0.54
DAO P14920 1/20 0.52
CA1 P00915 2/20 0.52
CA2 P00918 2/20 0.52
HCAR2 Q8TDS4 2/20 0.52
CYP1A2 P05177 2/20 0.52
CYP3A4 P08684 2/20 0.52
CYP2D6 P10635 2/20 0.52
CYP2C19 P33261 2/20 0.52
PLOD2 O00469 1/20 0.52
PLOD3 O60568 1/20 0.52
CYP2C9 P11712 1/20 0.52
HPGD P15428 1/20 0.52
PLOD1 Q02809 1/20 0.52
HIF1A Q16665 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isonicotinic Acid SCHEMBL1108 0.97
Isonicotinic Acid SCHEMBL1414914 0.97 NAPRT (1.00) NAPRTMEN1KMT2ATSHRTP53
Isonicotinic Acid SCHEMBL25222705 0.94 NAPRT (0.94) NAPRTMEN1KMT2ATSHRTP53
Isonicotinic Acid SCHEMBL25270920 0.94 NAPRT (0.94) NAPRTMEN1KMT2ATSHRTP53
Isonicotinic Acid SCHEMBL15401690 0.94 NAPRT (0.94) NAPRTMEN1KMT2ATSHRTP53
Isonicotinic Acid SCHEMBL25269381 0.94 NAPRT (0.94) NAPRTMEN1KMT2ATSHRTP53
Isonicotinic Acid SCHEMBL25271512 0.94 NAPRT (0.94) NAPRTMEN1KMT2ATSHRTP53
Isonicotinic Acid SCHEMBL25273146 0.94 NAPRT (0.94) NAPRTMEN1KMT2ATSHRTP53
Isonicotinic Acid SCHEMBL25261208 0.94 NAPRT (0.94) NAPRTMEN1KMT2ATSHRTP53
Isonicotinic Acid SCHEMBL11870257 0.94 NAPRT (0.94) NAPRTMEN1KMT2ATSHRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240322260-A1 SECONDARY BATTERY AND ELECTRICAL APPARATUS CONTAINING THE SAME CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) 2024-09-26 US claimed
EP-4318701-A1 SECONDARY BATTERY AND ELECTRICAL APPARATUS COMPRISING SAME Contemporary Amperex Technology Co., Limited (CN) 2024-02-07 EP claimed
CN-117321818-A Secondary battery and electricity utilization device comprising same 宁德时代新能源科技股份有限公司 2023-12-29 CN claimed
WO-2023102793-A1 SECONDARY BATTERY AND ELECTRICAL APPARATUS COMPRISING SAME 宁德时代新能源科技股份有限公司 2023-06-15 WO claimed
US-20240322260-A1 SECONDARY BATTERY AND ELECTRICAL APPARATUS CONTAINING THE SAME CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) 2024-09-26 US disclosed
EP-4318701-A1 SECONDARY BATTERY AND ELECTRICAL APPARATUS COMPRISING SAME Contemporary Amperex Technology Co., Limited (CN) 2024-02-07 EP disclosed
CN-117321818-A Secondary battery and electricity utilization device comprising same 宁德时代新能源科技股份有限公司 2023-12-29 CN disclosed
WO-2023102793-A1 SECONDARY BATTERY AND ELECTRICAL APPARATUS COMPRISING SAME 宁德时代新能源科技股份有限公司 2023-06-15 WO disclosed
CN-104040032-B Paint-on technique improves 庄信万丰股份有限公司 2017-12-22 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240322260-A1 SECONDARY BATTERY AND ELECTRICAL APPARATUS CONTAINING THE SAME SOD1, SOD3, CAT NAPRT 3967/4885MEN1 3734/4885KMT2A 3713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.